Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, October 29, 2020

Design and Characterization of Hand Module for Whole-Arm Rehabilitation Following Stroke

It has been 13 years, what the fuck has your stroke hospital done with this? 

Do you prefer your hospital incompetence NOT KNOWING? OR NOT DOING?

Their reasons for doing nothing? There is absolutely no excuse for doing nothing. They should all be keel-hauled. 

Laziness? Incompetence? Or just don't care? No leadership? No strategy? Not my job?

 The latest here:

Design and Characterization of Hand Module for Whole-Arm Rehabilitation Following Stroke

Date of Publication: 20 August 2007 
 

Weekend Admission Tied to Higher Stroke Mortality

So plan your stroke accordingly along with making sure you have ALL THE CLASSIC SIGNS; drooping mouth, slurred speech, one side not working. You have to make damn sure your doctors recognize you have a stroke. YOUR RESPONSIBILITY, NOT YOUR DOCTORS!

Weekend Admission Tied to Higher Stroke Mortality 

HealthDay News — Patients admitted for hemorrhagic stroke on weekends have higher in-hospital mortality than those admitted on weekdays, according to a study published in the October issue of the Journal of Stroke & Cerebrovascular Diseases.

Birook Mekonnen, M.P.H., from the University of Georgia in Athens, and colleagues used data from the 2016 National Inpatient Sample to compare in-hospital weekend stroke admissions (ischemic or hemorrhagic) to weekday admissions.

The researchers found that crude stroke mortality was higher with weekend admissions. When adjusting for confounding variables, in-hospital mortality for hemorrhagic stroke patients was significantly greater for weekend admissions versus weekday admissions (22.0 versus 20.2 percent). Findings were similar for hemorrhagic stroke patients treated at rural hospitals (36.9 percent for weekend versus 25.7 percent for weekday admissions) and urban hospitals (21.1 versus 19.6 percent). For ischemic stroke, there was no difference seen for weekend versus weekday admissions at either rural or urban hospitals.

“Factors such as density of care providers, stroke centers, and patient level risky behaviors associated with the weekend effect on hemorrhagic stroke mortality need further investigation to improve stroke care services and reduce weekend effect on hemorrhagic stroke mortality,” the authors write.

Today’s Top Picks for You on Neurology Advisor

Continue Reading

Abstract/Full Text (subscription or payment may be required)

 

“Morning People” at Higher Risk of Alzheimer Disease

This is most certainly not me.

“Morning People” at Higher Risk of Alzheimer Disease

A higher risk of Alzheimer disease was associated with early risers, a new study published in Neurology reports. The study found no link between major depressive disorder and Alzheimer disease.

Although previous studies report comorbidity of depressive disorders and neurodegenerative diseases such as Alzheimer disease, the researchers wanted to find out if a causal relationship exists between them as well as between Alzheimer disease and other abnormal sleep patterns.

The researchers conducted a bidirectional two-sample Mendelian randomization (MR) study. A genome-wide association study used data from the UK Biobank, the Psychiatric Genomics Consortium database, and the International Genomics of Alzheimer’s Project.

The authors found no causal relationship between major depression and sleep-related phenotypes, nor did they find statistically significant relationships between major depression and Alzheimer disease.

Today’s Top Picks for You on Neurology Advisor

Continue Reading

“Morning people” had genetically higher risks of Alzheimer disease, a lower risk of insomnia, and shorter sleep duration. They were also less likely to report long sleep. They also found people with higher risk of Alzheimer disease generally have a lower risk of insomnia.

Limitations include the fact that MR may overestimate the effect of clinical intervention on outcomes. In addition, the researchers obtained data only from middle-age or older individuals.

“Future work could explore the genetic heterogeneity of depression syndromes to test for causal relationships between potentially aetiologically distinct sub-types of depression (eg, late-onset depression) and Alzheimer’s disease,” the researchers concluded.

Reference

Huang J, Zuber V, Matthews PM, Elliott P, Tzoulaki J, Dehghan A. Sleep, major depressive disorder, and Alzheimer disease: A Mendelian randomization study. Neurology. 2020 Oct 6;95(14):e1963-e1970. doi: 10.1212/WNL.0000000000010463

This article originally appeared on Psychiatry Advisor

 

Shared Underlying Pathways Found for Fatigue and Depression in MS

Could this explain the massive fatigue found in stroke survivors? WHOM DO WE ASK THAT FUCKINGLY SIMPLE QUESTION?

Shared Underlying Pathways Found for Fatigue and Depression in MS

Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in the mechanisms underlying chronic fatigue and symptoms associated with major depressive disorder (MDD) in multiple sclerosis (MS), according to study results published in Multiple Sclerosis and Related Disorders.

Study researchers sought to better understand the relationship between chronic fatigue and depression in MS, as well as their mutual underpinning pathways. To achieve this, they conducted a descriptive review consisting of a summary of findings from several studies in MS and MDD.

The kynurenine pathway (KP) of tryptophan metabolism represents an essential regulator of the production of neurotoxic and neuroprotective compounds. Study researches noted that kynurenine (KYN), as such, which is converted from tryptophan at the initial and rate-limiting step of KP, can cause symptoms of anxiety or depression. Some research suggests that the KP may play a role in the progression of MS, possibly by linking inflammation and excitotoxic neurodegeneration. In other studies, low tryptophan levels and a high KYN/tryptophan ratio were good predictors of depression in patients with MS.

Several studies have also linked gut dysbiosis and increased gut permeability to higher levels of depression and fatigue, particularly in the setting of MS. Additionally, increased gut permeability may be associated with changes in ceramide levels in MS. Ceramides have normally been increased in cases of depression and fatigue.

Today’s Top Picks for You on Neurology Advisor

Continue Reading

Unusual levels of proinflammatory cytokines have also been demonstrated in patients with MS, yet fewer studies have focused on the link between cytokines and depression severity in this population. One study indicated that m-RNA expression of TNF-α and IFN-γ are significantly associated with depression severity during an acute MS attack, whereas another uncovered correlations between IFN-γ production and depression in patients with MS.

According to the authors of the review article, longitudinal studies that measure “immune-inflammatory and KYN pathway biomarkers” are needed to improve “understanding of the underlying pathological mechanisms” associated with chronic fatigue and depression in MS.

Reference

Ormstad H, Simonsen CS, Broch L, Maes M, Anderson G, Celius EG. Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways. Mult Scler Relat Disord. 2020;46:102533. doi:10.1016/j.msard.2020.102533

 

Maine Northern Light Eastern Maine Medical Center receives Get with the Guidelines-Stroke Gold Plus Quality Achievement Award

Big fucking whoopee.

 

 But you tell us NOTHING ABOUT RESULTS. They remind us they 'care' about us multiple times but never tell us how many 100% recovered.  You have to ask yourself why they are hiding their incompetency by not disclosing recovery results. ARE THEY THAT FUCKING BAD?

Three measurements will tell me if the stroke hospital is possibly not completely incompetent; DO YOU MEASURE ANYTHING?  I would start cleaning the hospital by firing the board of directors, you can't let incompetency continue for years at a time.

There is no quality here if you don't measure the right things.

  1. tPA full recovery? Better than 12%?
  2. 30 day deaths? Better than competitors?
  3. rehab full recovery? Better than 10%?

 

You'll want to know results so call that hospital president(Whoever that is) RESULTS are; tPA efficacy, 30 day deaths, 100% recovery. Because there is no point in going to that hospital if they are not willing to publish results.

 The latest invalid chest thumping here:

 

  Maine Northern Light Eastern Maine Medical Center receives Get with the Guidelines-Stroke Gold Plus Quality Achievement Award 

BANGOR — Oct. 29 is World Stroke Day. According to the American Heart Association/American Stroke Association, stroke is the number five cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.

Northern Light Eastern Maine Medical Center is pleased to announce it has received the American Heart Association/American Stroke Association’s Get with The Guidelines Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized guidelines based on the latest scientific evidence.

EMMC earned the award, which it has done for the past nine years, by meeting specific quality measures for the diagnosis and treatment of stroke These measures include the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

“Northern Light Eastern Maine Medical Center is dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get with The Guidelines-Stroke initiative,” said EMMC neurologist and interim medical director for Northern Light Stroke Care Roople Unia, MD. “The tools provided help us track adherence to evidence-based clinical guidelines designed to improve patient outcomes. Additionally, we are using telemedicine in partnership with Massachusetts General Hospital to improve access to stroke care for the people of Maine.”

 

WATCH | World-first technology helps stroke sufferers walk again

To me this would seem to be much much faster than getting strapped into the Lokomat.

WATCH | World-first technology helps stroke sufferers walk again

Australian stroke patients will be among the first in the world to access cutting-edge rehabilitation technology.

The robot assisted therapy device LEXO assists walking for those with neurological disabilities.

Click PLAY to see the LEXO machine in action; looks like you will have to go to the link to see it in action.

Stroke Day.mp4
Current Time 0:23
Duration 0:23
 

 

Advanced Rehab Centre CEO Melissa McConaghy was the first person to order a LEXO device, and told Jim Wilson the machine is essentially “a very, very sophisticated and glorified cross trainer”.

She expects people will travel from interstate, and eventually overseas, to seek LEXO therapy.

“I was looking in the gym one afternoon, and we had about three people working with one patient on a treadmill.

“It’s very exhausting work, and we can see that these patients really don’t achieve that many steps.

“I knew there has to be a better way.”

Click PLAY below to hear the full interview

On World Stroke Day, Australians are being urged to set themselves a ‘Stride for Stroke‘ challenge to reduce their risk.

More than three million Aussies are getting barely any exercise, and the Stroke Foundation’s Associate Professor Seana Gall told Jim Wilson the figures are “really alarming”.

“We know that very few people are doing the levels we need to see the prevention of diseases like stroke.”

Click PLAY below to hear the full interview


 

35-Year-Old Recovering After Chiropractic Adjustment Sparks Stroke

This is precisely why you NEVER get your neck adjusted. Your chiropractor has no clue how stiff your arteries are and whether there is plaque in them ready to be torn free. Has your doctor calculated the physics and knows EXACTLY the force not to rip the arteries or plaque apart? For a brief period of time, chiropractic applies 58% to 87% of the force of a suspended hanging. Do not listen to your chiropractor pooh-poohing this risk. Calculations here:

Chiropractic force

35-Year-Old Recovering After Chiropractic Adjustment Sparks Stroke

LOUISVILLE, Ky. — Katie Brooks said it can be frustrating trying to do everyday tasks like walking and putting on makeup. Her life was turned upside down four months ago when she suffered a stroke at just 35-years-old. She said she never envisioned this happening to her, especially not how it did.

35-year-old Katie Brooks suffered from a stroke COURTESY KATIE BROOKS

 

It all started when an injury sparked a trip to the chiropractor in June. When the chiropractor adjusted her neck, doctors said an artery was dissected sparking a stroke.

"Probably within two minutes, my right side started to go limp. I started drooling,” Brooks said.

Doctors with UofL Health say stroke caused by an artery dissection during a chiropractic adjustment is rare, but it is something they see. The National Center for Biotechnology Information reports vertebral artery dissection is the cause of around 2% of all ischemic strokes, but that same report finds the number rises to 10-25% for patients under 45.

The Centers for Disease Control and Prevention says stroke is now the fifth leading cause of death in the United States, down from having been the third leading cause of death. Dr. Michael Haboubi, a neurologist at UofL Health, said that decrease is likely because treatment is getting better and the public is more aware of stroke symptoms now, so people get life-saving treatment sooner. 

“1.9 million brain cells, neurons, die every minute that a large vessel stroke is going on, so getting to the hospital as soon as possible and getting treatment as soon as possible is extremely important,” Dr. Haboubi said.

Since early treatment is so important, doctors want everyone to be able to recognize the signs and symptoms. Experts use the acronym "Be Fast." You should seek immediate care if you have sudden changes to any of the following:

  • Balance: Does the person have a sudden loss of balance?
  • Eyes: Has the person lost vision in one or both eyes?
  • Face: Does the person's face look uneven?
  • Arms: Is one arm weak or numb?
  • Speech: Is the person's speech slurred? Does the person have trouble speaking? Does the person seem confused?
  • Time: If someone has any of those symptoms call 911 immediately.

Every minute can make a difference when someone has a stroke. Brooks recalls what it was like.

“Until I got to the emergency room, I was scared to close my eyes. I thought if I did, I wasn’t going to wake back up. Until they gave me that clot buster, I didn’t think I would have made it. I don’t think I would have recovered like I did,” Brooks said.

That initial life-saving treatment is just the start of what is often a long road to recovery. Many patients head to Frazier Rehab soon after having a stroke. Dr. Daryl Kaelin said about 25% of the patients at Frazier Rehab have had a stroke.

Katie Brooks continues to recover from the stroke that she suffered four months ago. COURTESY KATIE BROOKS

 

“The deficits that come from strokes including weakness, balance problems, language problems, thinking problems, and vision problems can all be rehabilitated getting people back to their fullest level of function,” Dr. Kaelin said.

He said it can take a year to a year and a half for stroke patients to make a full recovery. Brooks said it can be difficult to go through, but she is making progress.

“Now I have almost full mobility in my right side. I have a lot of issues right now because of the stroke," Brooks said."It’s been right at four months. Where I was to where I am now, it’s amazing the difference.”

She said patience is key, and she's hopeful about her recovery process as she works with experts at Frazier Rehab.

 

Lesion Age Imaging in Acute Stroke: Water Uptake in CT Versus DWI‐FLAIR Mismatch

 What the fuck difference does it make when the stroke stated? THE STROKE MEDICAL WORLD SHOULD HAVE PROTOCOLS FOR ALL SCENARIOS LEADING TO 100% RECOVERY. 

If they don't they should get them created. Until we get survivors in charge nothing will change. Your hospital has been incompetent for DECADES in not having these protocols right now.

 

Lesion Age Imaging in Acute Stroke: Water Uptake in CT Versus DWI‐FLAIR Mismatch

First published: 16 September 2020

Abstract

Purpose

In acute ischemic stroke with unknown time of onset, magnetic resonance (MR)‐based diffusion‐weighted imaging (DWI) and fluid‐attenuated inversion recovery (FLAIR) estimates lesion age to guide intravenous thrombolysis. Computed tomography (CT)‐based quantitative net water uptake (NWU) may be a potential alternative. The purpose of this study was to directly compare CT‐based NWU to magnetic resonance imaging (MRI) at identifying patients with lesion age < 4.5 hours from symptom onset.

Methods

Fifty patients with acute anterior circulation stroke were analyzed with both imaging modalities at admission between 0.5 and 8.0 hours after known symptom onset. DWI‐FLAIR lesion mismatch was rated and NWU was measured in admission CT. An established NWU threshold (11.5%) was used to classify patients within and beyond 4.5 hours. Multiparametric MRI signal was compared with NWU using logistic regression analyses. The empirical distribution of NWU was analyzed in a consecutive cohort of patients with wake‐up stroke.

Results

The median time between CT and MRI was 35 minutes (interquartile range [IQR] = 24–50). The accuracy of DWI‐FLAIR mismatch was 68.8% (95% confidence interval [CI] = 53.7–81.3%) with a sensitivity of 58% and specificity of 82%. The accuracy of NWU threshold was 86.0% (95% CI = 73.3–94.2%) with a sensitivity of 91% and specificity of 78%. The area under the curve (AUC) of multiparametric MRI signal to classify lesion age <4.5 hours was 0.86 (95% CI = 0.64–0.97), and the AUC of quantitative NWU was 0.91 (95% CI = 0.78–0.98). Among 87 patients with wake‐up stroke, 46 patients (53%) showed low NWU (< 11.5%).

Conclusion

The predictive power of CT‐based lesion water imaging to identify patients within the time window of thrombolysis was comparable to multiparametric DWI‐FLAIR MRI. A significant proportion of patients with wake‐up stroke exhibit low NWU and may therefore be potentially suitable for thrombolysis. ANN NEUROL 2020

In acute ischemic stroke, efficacy of intravenous thrombolysis depends on the time from symptom onset to admission, although some patients after a stroke may benefit even in an extended time window.1, 2 Current guidelines limit the application of intravenous thrombolysis to patients within a time window of ≤ 4.5 hours.3, 4 In approximately 25% of all ischemic strokes, symptoms are first apparent on awakening (“wake‐up strokes”) as onset occurs during sleep leading to an exclusion from treatment with alteplase. In these cases, neuroimaging can help to potentially enable intravenous lysis, a notion that is supported by the results of the WAKE‐UP and EXTEND trial that were based on imaging 2 different aspects of stroke pathophysiology. Based on tissue diffusion and tissue water content, the WAKE‐UP trial used magnetic resonance imaging (MRI) primarily as an indicator of lesion age in patients with an unknown time window.5 In contrast, the EXTEND trial used perfusion computed tomography (CT) to detect patients with stroke with a specific imaging pattern of tissue at risk, indicating a likely benefit from intravenous thrombolysis beyond 4.5 hours from symptom onset and in wake‐up stroke.6

As the number of patients who may receive intra‐arterial treatment increases (eg, more distal vessel occlusions, low ASPECTS, and extended time window), correspondingly, the proportion of patients who receive CT imaging at admission to ensure fast times from admission to recanalization rises.2, 7, 8 Therefore, CT‐based methods of patient eligibility for reperfusion treatment for patients with wake‐up strokes should be investigated further to enable intravenous treatment while maintaining options for rapid transfer to endovascular intervention.9 Translating the “tissue clock criteria” as used in WAKE‐UP from MRI to CT would complement the “tissue at risk” criteria by CT perfusion, as used in the EXTEND trial. Quantitative lesion water uptake is a CT‐based imaging biomarker that has been described as a precise method to estimate lesion age.10 Yet, this method has not been compared directly in patients who received both imaging modalities, CT and MRI, at admission. In the past, performing CT and MRI was often part of standard imaging upon admission.11

The aim of this study was (1) to compare CT‐based quantitative net water uptake (NWU) to multiparametric MRI (diffusion‐weighted imaging [DWI] and fluid‐attenuated inversion recovery [FLAIR]) in classifying patients below or above an acute ischemic lesion age of 4.5 hours, and (2) to analyze the distribution of NWU in a cohort of consecutive patients with wake‐up strokes to investigate potential eligibility of CT‐guided thrombolysis. We hypothesized that CT‐based NWU may represent a feasible alternative to MRI‐based DWI‐FLAIR mismatch to distinguish patients within a 4.5 hours time window.

 

Wednesday, October 28, 2020

The Michael J. Fox Foundation has had an ambitious goal: find a cure for Parkinson’s disease.

And our fucking failures of stroke associations don't even have curing stroke as a goal. They seem to think nothing further needs to be done as proven by this meme from World Stroke Day a few years ago. I would fire the lot of them including all the boards of directors of stroke hospitals for gross incompetence in not even trying to solve stroke. 

For those not enlightened these two links prove how fucking bad stroke is;  All the problems in stroke, or this nihilism list.

I look forward to all the 'stroke leaders' in the world trying to prove me wrong in my assessment. Leaders solve problems they don't 

RUN AWAY!

with their tail between their legs.

 

What a lying piece of shit.


 The Michael J. Fox Foundation has had an ambitious goal: find a cure for Parkinson’s disease.

 

Dear Friend,

Since opening our doors in 2000, The Michael J. Fox Foundation has had an ambitious goal: find a cure for Parkinson’s disease. Today, we’re closer than ever.

Learn about 20 years of scientific progress in the Parkinson’s therapeutic pipeline and what’s to come next by joining our Virtual Research Roundtable on Tuesday, November 17 at 3 p.m. ET. Save your seat — and ask your questions of the expert panelists in advance.

We look forward to seeing you online.


P.S. Please feel free to share the registration link with your friends, family and local community members who may be interested in attending.

Bayhealth(Delaware) earns highest national stroke award honors

 

Big fucking whoopee.

 

 But you tell us NOTHING ABOUT RESULTS. They remind us they 'care' about us multiple times but never tell us how many 100% recovered.  You have to ask yourself why they are hiding their incompetency by not disclosing recovery results. ARE THEY THAT FUCKING BAD?

Three measurements will tell me if the stroke hospital is possibly not completely incompetent; DO YOU MEASURE ANYTHING?  I would start cleaning the hospital by firing the board of directors, you can't let incompetency continue for years at a time.

There is no quality here if you don't measure the right things.

  1. tPA full recovery? Better than 12%?
  2. 30 day deaths? Better than competitors?
  3. rehab full recovery? Better than 10%?

 

You'll want to know results so call that hospital president(Whoever that is) RESULTS are; tPA efficacy, 30 day deaths, 100% recovery. Because there is no point in going to that hospital if they are not willing to publish results.

 The latest invalid chest thumping here:

Bayhealth(Delaware) earns highest national stroke award honors

Bayhealth Hospital, Kent Campus and Bayhealth Hospital, Sussex Campus have received the American Heart Association/American Stroke Association’s Get With The Guidelines Stroke Gold Plus Quality Achievement Award.

This is the second consecutive year that both hospitals have been recognized at the highest level of this national awards program. This achievement demonstrates the strong commitment at Bayhealth to ensuring that stroke patients receive the most appropriate treatment according to nationally recognized guidelines based on the latest scientific evidence.

The two hospitals earned these awards by meeting specific quality measures for the diagnosis and treatment of stroke patients at a set level for a designated period. One measure is evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date guidelines to speed recovery and reduce death and disability for stroke patients. Another quality measure demonstrated by Bayhealth was providing education to patients before discharge to help them manage their health, arranging transitions of care and getting follow-up visits scheduled.

“The tools and resources provided by the Get With The Guidelines - Stroke initiative help us track and measure our continued success as we follow proven guidelines in treating stroke. It’s an honor to receive this award, and more importantly, we are proud of our team’s dedication to exceptional care that improves outcomes for our stroke patients,” said Dr. Sumeet Multani, Bayhealth interventional neurologist and medical director of neurology.

Bayhealth Kent and Sussex campuses also received the association’s Target: Stroke Elite Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. Both hospitals are designated as Primary Stroke Centers, featuring a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the emergency department.

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds, and nearly 795,000 people suffer a new or recurrent stroke each year.

Visit Bayhealth.org/Neurosciences to learn more about stroke care.

 

Biomechanical control of paretic lower limb during imposed weight transfer in individuals post-stroke

So fucking what, you described a problem but offered NO SOLUTION.

Biomechanical control of paretic lower limb during imposed weight transfer in individuals post-stroke

Abstract

Background

Stroke is a leading cause of disability with associated hemiparesis resulting in difficulty bearing and transferring weight on to the paretic limb. Difficulties in weight bearing and weight transfer may result in impaired mobility and balance, increased fall risk, and decreased community engagement. Despite considerable efforts aimed at improving weight transfer after stroke, impairments in its neuromotor and biomechanical control remain poorly understood. In the present study, a novel experimental paradigm was used to characterize differences in weight transfer biomechanics in individuals with chronic stroke versus able-bodied controls

Methods

Fifteen participants with stroke and fifteen age-matched able-bodied controls participated in the study. Participants stood with one foot on each of two custom built platforms. One of the platforms dropped 4.3 cm vertically to induce lateral weight transfer and weight bearing. Trials involving a drop of the platform beneath the paretic lower extremity (non-dominant limb for control) were included in the analyses. Paretic lower extremity joint kinematics, vertical ground reaction forces, and center of pressure velocity were measured. All participants completed the clinical Step Test and Four-Square Step Test.

Results

Reduced paretic ankle, knee, and hip joint angular displacement and velocity, delayed ankle and knee inter-joint timing, increased downward displacement of center of mass, and increased center of pressure (COP) velocity stabilization time were exhibited in the stroke group compared to the control group. In addition, paretic COP velocity stabilization time during induced weight transfer predicted Four-Square Step Test scores in individuals post-stroke.

Conclusions

The induced weight transfer approach identified stroke-related abnormalities in the control of weight transfer towards the paretic limb side compared to controls. Decreased joint flexion of the paretic ankle and knee, altered inter-joint timing, and increased COP stabilization times may reflect difficulties in neuromuscular control during weight transfer following stroke. Future work will investigate the potential of improving functional weight transfer through induced weight transfer training exercise.

Background

Stroke is a leading cause of death and serious long-term disability in the United States [1, 2]. Individuals with hemiparesis due to stroke commonly demonstrate difficulty bearing weight on the paretic lower extremity and transferring weight from one leg to the other [3,4,5]. Reduced paretic limb weight bearing has been associated with functional deficits when rising from a chair [6], standing [7], and walking [8, 9]. The ability to transfer bodyweight between the lower limbs is related to impaired standing and stepping balance [10, 11] and gait performance [3, 12]. In particular, diminished weight transfer to the paretic limb contributes to gait asymmetries, which commonly lead to greater energy expenditure [13]. Previously we reported the ability to transfer weight laterally to the paretic leg during single stance was associated with self-selected walking speed and the capacity to increase walking speed [14]. This may indicate that weight transfer deficits negatively affect forward progression. Indeed, forceful weight shift towards the paretic limb enhanced paretic lower extremity kinetics and muscle activities that contribute to forward progression [15]. Moreover, deficits in paretic limb weight-bearing contribute to lateral and vertical balance instability and are associated with risk of falling in individuals with chronic stroke [16]. These functional limitations can affect community participation and quality of life. Consequently, restoring the capacity to load the paretic limb is an important goal for rehabilitation post-stroke [17,18,19].

Despite considerable rehabilitation efforts aimed at improving weight transfer following a stroke [10, 20], the impairments in neuromotor and biomechanical control underlying weight transfer dysfunction remain poorly understood. Functional weight transfer requires the coordination of multi-joint actions to absorb the impact force and provide support to the body. In particular, the ankle and knee joints are key contributors to shock absorption [21,22,23,24] and body weight support [25]. Increased stiffness in the paretic limb knee and ankle joints has been reported in persons with stroke [26, 27]. Inadequate lower limb joint flexion may disrupt impact force regulation during weight acceptance and lead to instability that ultimately delays and prolongs weight transfer timing during locomotion. Alternatively, excessive ankle and knee joint flexion during loading may precipitate limb collapse and destabilize balance during weight transfer. Thus, both insufficient and excessive joint movement could affect weight transfer processes. In addition to the amplitude of paretic ankle and knee joint angular displacements, abnormalities in the relative timing of these joint motions (i.e., inter-joint coordination) may also contribute to impaired weight transfer following stroke.

Another key factor affecting functional weight transfer is the ability to regulate the center of pressure (COP) beneath the feet in relation to the body center of mass (COM). During locomotion, effective neuromotor control of the lower extremities contributes to regulating COM position and movement relative to the base of support to maintain stability and prevent falling. Compared with able-bodied adults, persons with chronic stroke have a reduced capacity to rapidly shift their COP to the stance limb during gait initiation [28], reflecting abnormalities in balance control during weight transfer. Because hip and ankle musculature regulates COM and COP movements [29], difficulties in controlling hip kinematics and hip-ankle joint coordination may contribute to delayed and reduced weight transfer after a stroke.

To further address the foregoing issues, this study examined the potential biomechanical factors that could affect lower paretic limb weight bearing and weight transfer performance following stroke. After stroke individuals often limit their use of the paretic limb by favoring the use of the less affected leg during stance and gait [30]. An approach that forces individuals to fully load the paretic limb is warranted to reveal the performance capacity and assess the control of weight bearing and weight transfer. Accordingly, we designed a novel system that vertically displaces the support surface underneath one leg and therefore imposes weight transfer. By unilaterally introducing a perturbation that drops the standing support surface, this approach forces a rapid alteration in inter-limb weight bearing distribution and challenges medial–lateral balance control.

The primary purpose of this study was to characterize the kinematics and kinetics of the paretic lower extremity during an externally induced weight transfer towards the paretic limb in chronic stroke compared to age-matched controls. We hypothesized that, compared with able-bodied individuals, those with chronic stroke would show reduced and uncoordinated paretic limb joint angular displacements, and prolonged stabilization time of the COP velocity following an externally induced weight transfer. In addition, relationships between measurements during imposed weight transfer, motor recovery assessment (i.e. Chedoke McMaster Stroke Assessment leg and foot subscale), and clinical limb loading and balance performance (i.e. Four-Square Step Test (FSST) and Step Test (ST)) were explored. We expected that COP velocity stabilization time and CMSA scores would be associated with FSST and ST scores.

 

Incorporating Artificial Intelligence Into Stroke Care and Research

 Why not just hire Dr. Watson? The IBM computer is already tackling other medical issues. Or don't you know about that?

Dr. Watson for stroke I wrote this in July 2020. 

Other uses by Dr. Watson:

VA partners with IBM to use supercomputer Watson to treat cancer

 

MD Anderson Cancer Center to Use IBM Watson

 

IBM Watson, Boston Children’s team on rare pediatric diseases

 

Multiple Sclerosis @Point of Care app with Dr. Watson

 

Fighting Diabetes with Watson: Medtronic & IBM Watson Health 

IBM Watson Makes a Treatment Plan for Brain-Cancer Patient in 10 Minutes; Doctors Take 160 Hours

 

HIMSS19: IBM Watson teams with Brigham, Vanderbilt on $50M AI research initiative

 

The latest here:


Incorporating Artificial Intelligence Into Stroke Care and Research

First page image

Tuesday, October 27, 2020

Failures in standing up from a couch or sofa

 Normal people use both arms to push up from a sitting position to standing. My left arm has zero ability to even get into proper position; the fingers will not open, the wrist will not lay flat, the lats immediately pull the arm to the chest wall. So I have to twist my body so my left cheek is on the edge of the chair, use my right am to push my upper body over my legs and then stand up straight, swaying for a bit before I take a first step with my good leg.  This will become a problem in 25-30 years when I'm not as strong and balanced as I am now. I see NO SOLUTION FOR ME EVER. I should be able to go to ANY THERAPIST IN THE WORLD and get exact protocols to solve this problem.

TSU developed a way to monitor the migration of young neurons

In what parallel universe do you live in if you think our fucking failures of stroke associations  will instruct researchers to use this to validate that their neurogenesis experiments are working as expected?

TSU developed a way to monitor the migration of young neurons

TSU neuroscientists and colleagues from Belgium and the USA have created a non invasive tool to track the movement of young neurons. To do this, scientists mark new brain cells with a special marker that can be seen on MRT (magnetic resonance tomography). Viral vectors - inactivated viruses that can easily enter the cell, act as delivery couriers of markers. The new tool, created with the support of the Russian Science Foundation, will help to predict the dynamics of patient recovery and assess the pace of rehabilitation after stroke and traumatic brain injury.

- It is known that after a stroke, in special zones of neurogenesis, there is an active production of young neurons. They migrate to the affected area to replace the dead neurons, - explains Marina Khodanovich, head of the Laboratory of Neurobiology at the TSU Biological Institute. - But before there were methods to track these cells in a living brain, this could only be understood postmortem. To see how young neurons travel, we and colleagues from the University of Leuven (Belgium) - Irina Thiry and Veronique Daniels - designed special vectors based on lentiviruses and adenoassociated viruses. Genetic engineers extracted a pathogenic component from them and inserted a gene that increases the production of ferritin, and also a special genetic sequence (promoter), thanks to which the production of ferritin will increase only in young neurons. Young neurons store ferritin, and therefore iron, which makes them visible. 

The researchers tested the new tool on rats. They simulated ischemic cerebral stroke in laboratory animals, introduced a genetic tag, and tracked the process of neurogenesis. The rats' brains were scanned on the most powerful high-field magnetic resonance imaging machine in Russia, designed for research on small laboratory animals.

- As part of the experiment, the condition of 40 stroke survivors was assessed, says Marina Khodanovich. During the month, each of them had several scans. On the MRT scans, we saw changes characteristic of iron accumulation. Then we examined sections of animal brains and identified cells that had accumulated ferritin. It turned out that the localization of changes in the MRT signal and the neurons that accumulated ferritin coincide well, and not only with young but also with adult neurons that are included in the neural network. This suggests that the first non invasive way to track new neurons using viral vectors is indeed effective.

According to the neurobiologist, this method cannot be used in humans, because an increase in ferritin content affects cell metabolism. But the new approach helps to understand and trace in animals how the brain recovers from stroke, injury, and other diseases. This knowledge will help create new therapies and predict brain recovery after severe disorders.

In the near future, scientists to analyze a large amount of information obtained during the experiment. This will make it possible not only to reveal new data on neurons but also to evaluate the functional characteristics of vectors, to choose the most effective and safe ones for changing the functions of neurons.

The new method makes it possible to monitor other cells of the nervous system that cannot yet be seen on MRT. For example, with ischemia, a glial scar appears around the focus - a kind of barrier that encloses the area in which the dead cells are located. Until a certain time, until the immune cells remove the "garbage" in the form of dead neurons, this scar is even useful, but later it interferes with the germination of axons (processes along which nerve impulses travel) and the restoration of the activity of the central nervous system.

- There is no way to non-invasively look at astrocytes - those cells that form a glial scar, but the use of viral vectors can solve this problem, - adds Marina Khodanovich. -– After labels are delivered to astrocytes, it will be possible to see their behavior. In the future, it is possible to find a way to change their morphology in order to destroy the glial scar and accelerate the patient's recovery process. This is just one use case for vectors. The potential of the new instrument is much broader.

As part of further research, neuroscientists of TSU intend to obtain a whole series of important data to find out the functional characteristics of new neurons and how fully they are included in the work of the neural network.


Provided by Tomsk State University